Now after selling majority of our generic products off which cost us something like 900 million and offloaded for about 90 million more than likely out South Aust plant will be next to go when that happens we'll be pretty much a specialty pharma company focused on US women's healthcare , hopefully we can grow from here and hopefully long time investors who invested in a completely different company than it is now ( transformation ) have an chance to recover some money lost under SR hope so anyway . MYX probably regarded as a speculative stock with considerable potential , we should be seen as great value (cheap) now but now after consolidation buyers ending up with way fewer shares than they did before consolidation making shares look expensive whilst still on the ASX , listing on the US exchange sure going forward .
MYX Price at posting:
$4.07 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)